Treatment of immunocompromised COVID‐19 patients with convalescent plasma

Immunosuppressed patients such as solid organ transplant and hematologic malignancy patients appear to be at increased risk for morbidity and mortality due to coronavirus disease 2019 (COVID‐19) caused by SARS coronavirus 2 (SARS‐CoV‐2). Convalescent plasma, a method of passive immunization that has...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Transpl Infect Dis
Auteurs principaux: Fung, Monica, Nambiar, Ashok, Pandey, Suchi, Aldrich, J. Matthew, Teraoka, Justin, Freise, Christopher, Roberts, John, Chandran, Sindhu, Hays, Steven R., Bainbridge, Emma, DeVoe, Catherine, Roque Gardner, Annelys, Yokoe, Deborah, Henrich, Timothy J., Babik, Jennifer M., Chin‐Hong, Peter
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2020
Sujets:
Case Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537112/
https://ncbi.nlm.nih.gov/pubmed/32989856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tid.13477
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires